In Silico Screening, Synthesis and In Vitro Evaluation of Some Quinazolinone and Pyridine Derivatives as Dihydrofolate Reductase Inhibitors for Anticancer Activity
Dihydrofolate reductase (DHFR) is the important target for anticancer drugs belonging to the class of antimetabolites as the enzyme plays important role in the de novo purine synthesis. We here report the in silico screening to obtain best fit molecules as DHFR inhibitors, synthesis of some ʻbest fi...
Main Authors: | A. G. Nerkar, A. K. Saxena, S. A. Ghone, A. K. Thaker |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2009-01-01
|
Series: | E-Journal of Chemistry |
Online Access: | http://dx.doi.org/10.1155/2009/506576 |
Similar Items
-
In Silico Screening of the Library of Pyrimidine Derivatives as Thymidylate Synthase Inhibitors for Anticancer Activity
by: A. G. Nerkar, et al.
Published: (2009-01-01) -
Specificity of inhibitor binding to dihydrofolate reductase
by: Bevan, A. W.
Published: (1985) -
Non-classical inhibitors of dihydrofolate reductase
by: Chui, Wai K.
Published: (1990) -
Construction of Anticancer Drug Screening System by Recombinant Human Dihydrofolate Reductase
by: Shin-Yi Huang, et al.
Published: (2003) -
In Silico Study Probes Potential Inhibitors of Human Dihydrofolate Reductase for Cancer Therapeutics
by: Rabia Mukhtar Rana, et al.
Published: (2019-02-01)